Barclays
ACHC icon

Barclays’s Acadia Healthcare ACHC Stock Holding History

Barclays’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.96M Sell
126,681
-181,715
-59% -$3.29M ﹤0.01% 2123
2025
Q4 		$4.38M Buy
308,396
+198,435
+180% +$3.75M ﹤0.01% 2320
2025
Q3 		$2.72M Sell
109,961
-96,060
-47% -$2.14M ﹤0.01% 2633
2025
Q2 		$4.67M Buy
206,021
+52,855
+35% +$1.25M ﹤0.01% 2189
2025
Q1 		$4.64M Buy
153,166
+6,958
+5% +$265K ﹤0.01% 1973
2024
Q4 		$5.8M Buy
146,208
+36,189
+33% +$1.63M ﹤0.01% 2017
2024
Q3 		$6.98M Sell
110,019
-577,601
-84% -$41.7M ﹤0.01% 1767
2024
Q2 		$46.4M Buy
687,620
+594,194
+636% +$41.5M 0.01% 643
2024
Q1 		$7.4M Buy
93,426
+10,975
+13% +$897K ﹤0.01% 1592
2023
Q4 		$6.41M Buy
82,451
+29,610
+56% +$2.19M ﹤0.01% 1886
2023
Q3 		$3.72M Sell
52,841
-7,000
-12% -$523K ﹤0.01% 1511
2023
Q2 		$4.77M Buy
59,841
+38,431
+180% +$2.78M ﹤0.01% 1373
2023
Q1 		$1.55M Buy
21,410
+3,742
+21% +$292K ﹤0.01% 2399
2022
Q4 		$1.45M Buy
17,668
+8,180
+86% +$674K ﹤0.01% 2492
2022
Q3 		$742K Sell
9,488
-6,922
-42% -$553K ﹤0.01% 2438
2022
Q2 		$1.11M Buy
16,410
+12,172
+287% +$849K ﹤0.01% 2267
2022
Q1 		$277K Sell
4,238
-19,819
-82% -$1.15M ﹤0.01% 3239
2021
Q4 		$1.46M Sell
24,057
-27,512
-53% -$1.64M ﹤0.01% 2575
2021
Q3 		$3.29M Sell
51,569
-2,029
-4% -$128K ﹤0.01% 1936
2021
Q2 		$3.36M Buy
53,598
+46,227
+627% +$2.9M ﹤0.01% 1836
2021
Q1 		$422K Sell
7,371
-31,086
-81% -$1.68M ﹤0.01% 3278
2020
Q4 		$1.93M Sell
38,457
-12,478
-24% -$497K ﹤0.01% 2256
2020
Q3 		$1.5M Sell
50,935
-70,054
-58% -$2.03M ﹤0.01% 2350
2020
Q2 		$3.04M Sell
120,989
-1,117
-0.9% -$27.9K ﹤0.01% 1756
2020
Q1 		$2.24M Buy
122,106
+26,025
+27% +$745K ﹤0.01% 2184
2019
Q4 		$3.19M Buy
96,081
+30,937
+47% +$969K ﹤0.01% 2490
2019
Q3 		$2.03M Sell
65,144
-349,599
-84% -$10.6M ﹤0.01% 2848
2019
Q2 		$14.5M Buy
414,743
+295,395
+248% +$9.55M 0.01% 1115
2019
Q1 		$3.5M Sell
119,348
-4,906
-4% -$139K ﹤0.01% 1986
2018
Q4 		$3.19M Buy
124,254
+21,402
+21% +$741K ﹤0.01% 1948
2018
Q3 		$3.62M Sell
102,852
-5,791
-5% -$231K ﹤0.01% 2161
2018
Q2 		$4.45M Sell
108,643
-300,413
-73% -$12.1M ﹤0.01% 1819
2018
Q1 		$16M Buy
409,056
+324,988
+387% +$11.9M 0.01% 959
2017
Q4 		$2.74M Buy
84,068
+61,921
+280% +$2.15M ﹤0.01% 2148
2017
Q3 		$1.06M Buy
22,147
+15,398
+228% +$750K ﹤0.01% 2940
2017
Q2 		$333K Sell
6,749
-5,209
-44% -$231K ﹤0.01% 3903
2017
Q1 		$523K Sell
11,958
-49,280
-80% -$2M ﹤0.01% 3358
2016
Q4 		$2.03M Buy
61,238
+36,449
+147% +$1.41M ﹤0.01% 2110
2016
Q3 		$1.23M Buy
24,789
+4,335
+21% +$226K ﹤0.01% 2433
2016
Q2 		$1.13M Buy
20,454
+12,510
+157% +$732K ﹤0.01% 2501
2016
Q1 		$437K Sell
7,944
-4,053
-34% -$231K ﹤0.01% 3265
2015
Q4 		$744K Sell
11,997
-3,395
-22% -$221K ﹤0.01% 2874
2015
Q3 		$1.02M Sell
15,392
-7,285
-32% -$560K ﹤0.01% 2689
2015
Q2 		$1.77M Sell
22,677
-2,471
-10% -$178K ﹤0.01% 2330
2015
Q1 		$1.79M Buy
25,148
+10,710
+74% +$687K ﹤0.01% 2429
2014
Q4 		$882K Buy
14,438
+2,999
+26% +$175K ﹤0.01% 3327
2014
Q3 		$548K Buy
11,439
+1,526
+15% +$74.6K ﹤0.01% 3875
2014
Q2 		$446K Buy
9,913
+8,464
+584% +$372K ﹤0.01% 4091
2014
Q1 		$66K Sell
1,449
-7,240
-83% -$357K ﹤0.01% 5764
2013
Q4 		$409K Buy
8,689
+7,015
+419% +$305K ﹤0.01% 4300
2013
Q3 		$65K Sell
1,674
-162
-9% -$6.01K ﹤0.01% 5917
2013
Q2 		$61K Buy
+1,836
New +$59.6K ﹤0.01% 6167

Other funds holding ACHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Barclays's ACHC Position: Q1 2026 in Review

Barclays reduced its Acadia Healthcare (ACHC) stake by 59% in Q1 2026, selling an estimated $3.29M and leaving 126,681 shares worth $2.96M. The position accounts for ﹤0.01% of the portfolio, ranked #2123.

Barclays first reported a position in ACHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $46.4M in Q2 2024. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Barclays held 126,681 shares of Acadia Healthcare worth $2.96M as of Q1 2026.
  • Barclays sold 181,715 Acadia Healthcare shares in Q1 2026, an estimated $3.29M.
  • Acadia Healthcare made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2123 holding.
  • Barclays first reported a position in Acadia Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Acadia Healthcare position peaked at $46.4M in Q2 2024.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.